NextGen ALL risk stratification gene panel- B-ALL, Blood
NextGen ALL Risk Stratification Gene Panel by NGS - B-ALL, EDTA Blood** Price
Brief Details
What is a NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood?
The NextGen ALL Risk Stratification Gene Panel is an advanced genetic test that uses Next Generation Sequencing (NGS) technology to examine specific genes in your blood sample. This test is designed specifically for patients diagnosed with B-cell Acute Lymphoblastic Leukaemia (B-ALL).
The test helps doctors understand the genetic makeup of your leukaemia cells, which guides treatment decisions and helps predict how well you might respond to different therapies.
What Does the NextGen ALL Risk Stratification Gene Panel Measure?
This comprehensive NGS sequencing test measures several important aspects of your leukaemia:
- Genetic mutations - Identifies specific DNA changes in cancer cells that affect how the disease behaves.
- Gene deletions and fusions - Detects missing gene parts or abnormal gene combinations.
- Risk markers - Determines genetic factors that predict treatment response and disease outcome.
- Therapeutic targets - Identifies genetic weaknesses that can be targeted with specific medicines.
- Chemotherapy response indicators - Helps predict how well standard ALL leukaemia treatments will work.
- Residual disease markers - Assists in monitoring treatment effectiveness and detecting relapse.
NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood: Who Needs It and Why It's Done
What Symptoms May Call for a NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood?
This test is not ordered based on initial symptoms. It is performed after a patient has already been diagnosed with B-ALL. However, the original symptoms that lead to B-ALL diagnosis may include:
- Persistent fever and frequent infections
- Extreme fatigue and weakness
- Pale appearance
- Easy bruising and unusual bleeding
- Bone and joint pain
- Swollen lymph nodes in the neck, underarms, or groin
- Unexplained weight loss and loss of appetite
Who should get a NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood Test?
This specialised test is recommended for specific patient groups:
- Newly diagnosed B-ALL patients - Both children and adults who have been confirmed to have B-cell acute lymphoblastic leukaemia.
- Patients requiring B-ALL risk stratification - Those who need precise classification of their leukaemia type.
- Treatment planning candidates - Individuals whose doctors need genetic information to design personalised therapy.
Why is a NextGen ALL Risk Stratification Gene Panel done?
This test is performed to personalise your cancer treatment by identifying the specific genetic characteristics of your leukaemia, allowing doctors to choose the most effective treatment approach for your individual case.
Importance of a NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood
This genetic panel plays a crucial role in modern leukaemia care by providing essential information for treatment decisions. The test helps with B-ALL risk stratification by classifying patients into different risk groups—low, standard, or high risk—which determines the intensity of treatment needed.
For low-risk patients, the test may indicate that less intensive chemotherapy will be effective, reducing long-term side effects. High-risk patients can be identified early and may benefit from more intensive treatment or consideration for stem cell transplantation. The panel also identifies specific genetic targets that can be treated with newer, more precise medicines called targeted therapies, which often work better than traditional chemotherapy with fewer side effects.
NextGen ALL Risk Stratification Gene Panel Booking & Reports – Metropolis Healthcare India
How to Book a NextGen ALL Risk Stratification Gene Panel?
- Simple Online Booking
Booking can be done through the Metropolis Healthcare App or website. Select the NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood, choose a convenient time slot, and provide your address for a blood test at home. You can also visit the nearest Metropolis Lab if you prefer to give the sample directly at the lab.
- Safe Home Sample Collection
Our trained phlebotomists ensure the timely collection of your sample while strictly following all safety and hygiene protocols.
- Sample Tracking Updates
Stay informed at every step. From collection to testing, you can track your sample directly through the Metropolis Healthcare website.
- Accurate Laboratory Testing
Your sample is processed at our NABL & CAP accredited laboratories, where expert technicians ensure accurate results.
- Quick & Easy Reports
Receive your test reports promptly via email, WhatsApp, or by downloading them directly from the Metropolis Healthcare website or app.
Is home sample collection for NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood available near you?
Yes, Metropolis Healthcare provides home blood sample collection for the NextGen ALL Risk Stratification Gene Panel- B-ALL Blood test. Our trained phlebotomists follow strict safety protocols while collecting your blood sample in the comfort of your home. This service ensures you receive the same accurate, reliable results from our NABL & CAP accredited laboratories without the stress of travelling.
How Long Does It Take to Get a NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood Report?
Reports are usually available after 20 days once the sample reaches the lab.
Note: Reporting time may vary depending on your location.
Where can I see or get NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood results?
Test results from Metropolis Healthcare can be accessed through multiple convenient channels. You can log in to the Metropolis website using your credentials or use the Metropolis Healthcare App to view and download your reports. Additionally, test reports are sent via email or WhatsApp, and you also have the option to collect a physical copy directly from the lab.
Interpreting NextGen ALL Risk Stratification Gene Panel Results
What Your NextGen ALL Risk Stratification Gene Panel Results May Indicate
The following table explains how to understand your genetic test results and their clinical significance:
|
Gene/Parameter |
Result Type |
Clinical Significance |
|
NRAS mutations |
Pathogenic variant detected |
Associated with higher relapse risk and may require more intensive treatment. |
|
Hotspot genes (ABL1, FLT3, JAK2, KRAS) |
Mutation present/absent |
Indicates specific targeted therapy options and treatment response prediction. |
|
Full genes (ETV6, IKZF1, TP53) |
Variant classification |
Determines risk stratification and influences chemotherapy intensity. |
|
Gene fusions |
Fusion detected/not detected |
Identifies specific leukaemia subtypes requiring tailored treatment approaches |
|
Overall risk assessment |
Low/Standard/High risk |
Guides treatment intensity and monitoring frequency |
Conditions that May Affect NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood Accuracy
Several factors can influence the accuracy of your genetic panel results:
- Sample quality - Haemolysed, clotted, or insufficient blood samples may affect test accuracy.
- Previous treatments - Recent chemotherapy or radiation may alter genetic profiles in circulating cells.
- Sample storage - Improper temperature conditions during transport can impact DNA quality.
- Blood transfusions - Recent transfusions can dilute your own leukaemia cells in the sample.
- Disease progression - Genetic changes may evolve over time as leukaemia progresses.
- Technical limitations - Some genetic regions are difficult to sequence accurately due to their structure.
- Medication interference - Certain medicines may affect the quality of genetic material in blood samples.
How is a NextGen ALL Risk Stratification Gene Panel Done?
The genetic testing process involves minimal steps for blood sample collection:
- A healthcare professional cleans the area on your arm with an antiseptic.
- A tourniquet is placed around your upper arm to make the veins easier to see.
- A small needle is gently inserted into a vein to take a small amount of blood.
- The blood is collected into an EDTA tube.
- The needle is removed, and a bandage is applied to the puncture site.
- Your sample is correctly labelled and sent to the pathology lab for testing.
- The whole procedure takes only a few minutes and usually causes minimal discomfort.
How Should You Prepare for a NextGen ALL Risk Stratification Gene Panel?
Preparing for this genetic test is straightforward and requires minimal preparation:
- No fasting required - You can eat and drink normally before the test.
- Continue regular medications - Unless specifically advised otherwise by your doctor.
- Bring the required documents - Clinical history, histopathology reports, and medical prescriptions.
- Wear comfortable clothing - Choose clothing that allows easy access to your arm for blood collection.
- Inform about recent treatments - Tell your healthcare provider about any recent chemotherapy, blood transfusions, or other treatments.
Diseases that a NextGen ALL Risk Stratification Gene Panel Can Help Detect
This specialised genetic panel helps in the comprehensive assessment of B-ALL:
- High-risk B-ALL subtypes - Identifies genetic markers associated with aggressive disease.
- Treatment-resistant leukaemia - Detects genetic markers associated with chemotherapy resistance.
- Relapse risk assessment - Identifies patients at higher risk of disease recurrence.
- Minimal residual disease - Helps monitor treatment response and detect early relapse.
- Secondary genetic changes - Identifies additional mutations that may develop over time.
- Therapy response prediction - Identifies genetic markers that predict treatment effectiveness.
NextGen ALL Risk Stratification Gene Panel- B-ALL, Blood/Packages that You Can Book With Metropolis Healthcare
Related diagnostic tests are available to provide a comprehensive leukaemia evaluation:
|
Test/Package Name |
Purpose/Highlights |
|
Monitors minimal residual disease in B-cell ALL patients during treatment. |
|
|
Monitors minimal residual disease in T-cell ALL patients during treatment. |
|
|
Comprehensive panel for diagnosing and classifying various types of acute leukaemia. |
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.